Vicky A Jespers

Summary

Affiliation: Institute of Tropical Medicine
Country: Belgium

Publications

  1. ncbi Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers
    Vicky A Jespers
    Institute of Tropical Medicine, Antwerp, Belgium
    J Acquir Immune Defic Syndr 44:154-8. 2007
  2. ncbi Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men
    Vicky Jespers
    Institute of Tropical Medicine, Antwerp, Belgium
    Sex Transm Dis 34:519-22. 2007
  3. ncbi Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials
    Vicky Jespers
    Institute of Tropical Medicine, Nationalestraat 155, Antwerp, Belgium
    Am J Reprod Immunol 65:368-76. 2011
  4. ncbi Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection
    Tania Crucitti
    HIV STD Research and Intervention Unit, Institute of Tropical Medicine, 155 Nationalestraat, 2000 Antwerp, Belgium
    Diagn Microbiol Infect Dis 57:97-9. 2007
  5. ncbi Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia
    Tania Crucitti
    HIV STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium
    PLoS ONE 6:e16310. 2011
  6. ncbi Penile application of dextrin sulphate gel (Emmelle)
    Lut Van Damme
    Institute of Tropical Medicine, Antwerp, Belgium
    Contraception 66:133-6. 2002
  7. ncbi Assessment of mucosal immunity to HIV-1
    Vicky Jespers
    HIV STI Epidemiology and Control Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerpen, Belgium
    Expert Rev Vaccines 9:381-94. 2010

Detail Information

Publications7

  1. ncbi Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers
    Vicky A Jespers
    Institute of Tropical Medicine, Antwerp, Belgium
    J Acquir Immune Defic Syndr 44:154-8. 2007
    ..To evaluate the short-term safety, tolerability, and systemic exposure of a vaginal microbicide gel containing the nonnucleoside reverse transcriptase inhibitor TMC120...
  2. ncbi Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men
    Vicky Jespers
    Institute of Tropical Medicine, Antwerp, Belgium
    Sex Transm Dis 34:519-22. 2007
    ..Cellulose sulfate (CS) is a promising vaginal microbicide. Because men will be exposed to the microbicide when engaging in vaginal intercourse, safety and acceptability need to be assessed in men...
  3. ncbi Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials
    Vicky Jespers
    Institute of Tropical Medicine, Nationalestraat 155, Antwerp, Belgium
    Am J Reprod Immunol 65:368-76. 2011
    ..In this paper, we will discuss methods for vaginal immunology sampling in the context of clinical trials...
  4. ncbi Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection
    Tania Crucitti
    HIV STD Research and Intervention Unit, Institute of Tropical Medicine, 155 Nationalestraat, 2000 Antwerp, Belgium
    Diagn Microbiol Infect Dis 57:97-9. 2007
    ..We therefore recommend that the effects of microbicide gels on diagnostic assays of sexually transmitted infections be established before starting up clinical studies...
  5. ncbi Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia
    Tania Crucitti
    HIV STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium
    PLoS ONE 6:e16310. 2011
    ..To identify risk factors for trichomoniasis among young women in Ndola, Zambia...
  6. ncbi Penile application of dextrin sulphate gel (Emmelle)
    Lut Van Damme
    Institute of Tropical Medicine, Antwerp, Belgium
    Contraception 66:133-6. 2002
    ..Results from laboratory evaluations, genital examinations, and adverse events reports showed that 4% DS gel administered topically to the penis was well tolerated when compared with placebo...
  7. ncbi Assessment of mucosal immunity to HIV-1
    Vicky Jespers
    HIV STI Epidemiology and Control Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerpen, Belgium
    Expert Rev Vaccines 9:381-94. 2010
    ....